Improving the quantification of rSIV.F/HN vectors for cystic fibrosis gene therapy using droplet digital PCR
Main Authors: | Gamlen, T, Viegas, MFA, Dean, RJ, Conway, CC, Miah, KM, Gill, DR, Hyde, SC |
---|---|
Format: | Conference item |
Language: | English |
Published: |
Elsevier
2020
|
Similar Items
-
Rapid determination of rSIV.F/HN lentiviral vector titre
by: Conway, CC, et al.
Published: (2020) -
Large-scale, high-throughput production of rSIV.F/HN vectors
by: Viegas, MFA, et al.
Published: (2020) -
Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
by: Sergijenko, A, et al.
Published: (2021) -
Pre-existing immunity to human parainfluenza virus (hPIV) does not affect rSIV.F/HN-mediated transduction efficiency
by: Pytel, K, et al.
Published: (2016) -
Emerging gene therapies for cystic fibrosis
by: Miah, K, et al.
Published: (2019)